:: Volume 23, Issue 1 (Bimonthly 2019) ::
Feyz 2019, 23(1): 20-26 Back to browse issues page
The effect of ginger extract and vitamin K on serum levels of liver enzymes in NMRI mice with non-alcoholic fatty liver
Parisa Tavakoli , Hanyeh Jafary , Parichehreh Yaghmaei
Department of Biology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, I. R. Iran , parisa.tavakolli@yahoo.com
Abstract:   (4872 Views)
Background: Today, the fatty liver disease has been increased due to the wrong life-style. The aim of this study was to determine the effect of ginger extract and vitamin K on serum levels of liver enzymes in mice with non-alcoholic fatty liver.
Materials and Methods: In this study, male NMRI mice were randomly divided into six groups of five including control, sham (received high fat diet), positive control (received silymarin), ginger extract, vitamin K, ginger extract and vitamin K groups. The animals were injected daily with ginger extract and vitamin K (0.2 mg/kg i.p.) for four weeks. Serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) for evaluation of liver bile defects and liver function, and the activity of superoxide dismutase (SOD) and catalase (CAT) enzymes to determine the antioxidant status of the liver in serum was measured.
Results: Serum AST, ALT and ALP levels significantly decreased in ginger extract, vitamin K, ginger extract and vitamin K groups compared to the sham group (P<0.05). However, the serum levels of CAT and SOD were significantly increased (P<0.001).
Conclusion: Findings of this study show that due to antioxidant and anti-inflammatory properties of ginger extract, and also due to an important role of vitamin K in coagulation and proper liver function, ginger extract with vitamin K can improve the function of non-alcoholic fatty liver.
Keywords: Ginger, Vitamin K, Liver enzymes, Non-alcoholic fatty liver
Full-Text [PDF 218 kb]   (988 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2018/08/19 | Revised: 2019/04/17 | Accepted: 2019/02/19 | Published: 2019/04/17
References
1. Bhattarai S, Tran VH, Duke CC. The stability of gingerol and shogaol in aqueous solutions. J Pharm Sci 2001; 90(10): 1658-64.
2. Gupta YK, Sharma M. Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). Methods Find Exp Clin Pharmacol 2001; 23(9): 501-4.
3. O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used medicinal herbs. Arch Fam Med 1998; 7(6): 523.
4. Hafez DA. Effect of extracts of ginger goots and cinnamon bark on fertility of male diabetic rats. Am Sci 2010; 6(10): 940-7.
5. Afshari AT, Shirpoor A, Farshid A, Saadatian R, Rasmi Y, Saboory E, et al. The effect of ginger on diabetic nephropathy, plasma antioxidant capa‌city and lipid peroxidation in rats. Food Chem 2007; 101(1): 148-53.
6. Amin A, Hamza AA. Effects of Roselle and Ginger on cisplatin induced reproductive toxicity in rats. Asian J Androl 2006; 8(5): 607-12.
7. Rahimlou M, Yari Z, Hekmatdoost A, Alavian SM, Keshavarz S. Ginger supplementation in non‌alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study. Hepat Mon 2016; 16(1).
8. Bollman JL, Butt HR, Snell AM. The Influ‌ence of the Liver on the Utilization of Vitamin K. JAMA 1940; 115(13): 1087-91.
9. Hübscher SG. Histological assessment of non alcoholic fatty liver disease. Histopathology 2006; 49(5): 450-65.
10. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for non‌alcoholic fatty liver disease. Hepatology 2005; 41(6): 1313-21.
11. Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora J, et al. Hepatic tol‌erance of atypical antipsychotic drugs. Encephale 2002; 28(6 Pt 1): 542-51.
12. Suttner SW, Schmidt CC, Boldt J, Huttner I, Kumle B, Piper S, et al. Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients. Anesth Analg 2000; 91(1): 206-12.
13. Adias TC, Egerton E, Erhabor O. Evaluation of coagulation parameters and liver enzymes among alcohol drinkers in Port Harcourt, Nigeria. Int J Gen Med 2013; 6: 489.
14. Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, et al. Comprehensive analysis of com‌mon serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One 2012; 7(10): e47687.
15. Giboney P. Mildly elevated liver transaminase levels in the asymptomatic patient. Am Pham Physician 2005; 71(6): 1105-10.
16. Kelishadi R, Cook SR, Adibi A, Faghihimani Z, Ghatrehsamani S, Beihaghi A, et al. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal-weight, overweight and obese children and adol‌es‌cents. Diabetol Metab Syndr 2009; 1(1): 29.
17. Sakr SA, Mahran HA, Lamfon H. Protective effect of ginger (Zingiber officinale) on adriamycin-induced hepatotoxicity in albino rats. J Med Plant Res 2011; 5(1): 133-40.
18. Eslamparast T, Eghtesad S, Poustchi H, Hekm‌atdoost A. Recent advances in dietary supple‌men‌ta‌tion, in treating non-alcoholic fatty liver disease. World J Hepatol 2015; 7(2): 204.
19. Sood S, Narang D, Thomas M, Gupta Y, Maulik S. Effect of Ocimum sanctum Linn. on cardiac changes in rats subjected to chronic restraint stress. J Ethnopharmacol 2006; 108(3): 423-7.
20. Bhandari U, Shamsher AA, Pillai K, Khan M. Antihepatotoxic activity of ginger ethanol extract in rats. Pharmaceutical Biol 2003; 41(1): 68-71.
21. Modaresi M, Mesri por M, Ghobadi por M. Effect of hydroalcoholic Zingiber extract on creatinine and blood urea nitrogen (BUN) of mice. J Shahrekord Univ Med Sci 2006; 8(3): 48-53
22. Zou Y, Li J, Lu C, Wang J, Ge J, Huang Y, et al. High-fat emulsion-induced rat model of non‌alc‌o‌h‌olic steatohepatitis. Life Sci 2006; 79(11): 1100-7.
23. Garber JC, Barbee RW, Bielitzki JT, Clayton LA, Donovan JC, Hendriksen CF, et al. Guid for the care and use of laboratory animals. Washington: Thr national academies press; 1999.
24. Jeyakumar S, Nalini N, Menon V. Antioxidant activity of ginger (Zingiber officinale Rosc) in rats fed a high fat diet. Med Sci Res 1999; 27(5): 341-4.
25. Akhavan Rezayat K, Afkhamizadeh M, Chachi K, Salehi M. Evaluation of effect of helicobacter pylori treatment on insulin resistance in patients with nonalcoholic fatty liver disease. MJMS 2015; 58(8): 425-31.
26. Pournaderi PS, Yaghmaei P, Khodaei H, Noormohammadi Z, Hejazi SH. The effects of 6-Gingerol on reproductive improvement, liver functi‌oning and Cyclooxygenase-2 gene expression in estra‌diol valerate–Induced polycystic ovary synd‌rome in Wistar rats. Biochem Biophys Res Com‌mun 2017; 484(2): 461-66.
27. Motawi TK, Hamed MA, Shabana MH, Hashem RM, Aboul Naser AF. Zingiber officinale acts as a nutraceutical agent against liver fibrosis. Nutr Metab 2011; 8(1): 40
28. Liu CT, Raghu R, Lin SH, Wang SY, Kuo CH, Tseng YJ, et al. Metabolomics of ginger essential oil against alcoholic fatty liver in mice. J Agric Food Chem 2013; 61(46): 11231-40.
29. Ji K, Fang L, Zhao H, Li Q, Shi Y, Xu C, et al. Ginger Oleoresin Alleviated γ-Ray Irradiation-Indu‌ced Reactive Oxygen Species via the Nrf2 Prot‌ective Response in Human Mesenchymal Stem Cells. Oxid Med Cell Longev 2017; 2017.
30. Dahlberg S, Ede J, Schött U. Inves‌tiga‌tion‌Vitamin k and cancer. Scand J Clin Lab Invest 2017; 77(8): 555-67.
31. Dasari S, Ali SM, Zheng G, Chen A, Dontaraju VS, Bosland MC, et al. Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget 2017; 8(34): 57782-57799.
32. Ishibashi M, Arai M, Tanaka S, Onda K, Hirano T, Bulletin P. Antiproliferative and apop‌tos‌is-inducing effects of lipophilic vitamins on human melanoma A375 cells in vitro. Biol Pharm Bull 2012; 35(1): 10-7.
33. Zhong JH, Mo XS, Xiang BD, Yuan WP, Jiang JF, Xie GS, et al. Postoperative use of the chemo‌pre‌ventive vitamin K2 analog in patients with hepatocellular carcinoma. PLoS One 2013; 8(3): e58082.
34. Conly J, Stein K. Reduction of vitamin K2 con‌ce‌ntrations in human liver associated with the use‌ of broad spectrum antimicrobials. Clin Invest Med 1994; 17(6): 531.
35. Abdel-Azeem AS, Hegazy AM, Ibrahim KS, Far‌rag AR, El-Sayed EM. Hepatoprotective, anti‌oxidant, and ameliorative effects of ginger (Zin‌gib‌er officinale Roscoe) and vitamin E in aceta‌mino‌phe‌n treated rats. J Diet Suppl 2013; 10(3): 195-209.
36. Tamori A, Habu D, Shiomi S, Kubo S, Nish‌iguchi S. Potential role of vitamin K2 as a che‌mo‌preventive agent against hepatocellular carcinoma. Hepatol Res 2007; 37: S303-S7.
37. Heeba GH, Abd-Elghany MI. Effect of comb‌ined administration of ginger (Zingiber officinale Ros‌coe) and atorvastatin on the liver of rats. Phyt‌omed 2010; 17(14): 1076-81.

XML   Persian Abstract   Print

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 23, Issue 1 (Bimonthly 2019) Back to browse issues page